Dr. Spelbrink is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
725 Welch Rd
Palo Alto, CA 94304Phone+1 650-736-0885Fax+1 310-328-0864
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Child Neurology, 2012 - 2015
Los Angeles County-Harbor-UCLA Medical CenterResidency, Pediatrics, 2010 - 2012
University of California San Diego School of MedicineClass of 2010
Certifications & Licensure
HI State Medical License 2019 - 2026
CA State Medical License 2011 - 2025- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Epilepsy
Publications & Presentations
PubMed
- 7 citationsCharacterizing a rare neurogenetic disease, SLC13A5 citrate transporter disorder, utilizing clinical data in a cloud-based medical record collection system.Emily M Spelbrink, Tanya L Brown, Elise Brimble, Kirsten A Blanco, Kimberly L Nye
Frontiers in Genetics. 2023-01-01 - 21 citationsEpilepsy and EEG Phenotype of SLC13A5 Citrate Transporter Disorder.Qian-Zhou Yang, Emily M. Spelbrink, Kimberly L. Nye, Emily R Hsu, Brenda E. Porter
Child Neurology Open. 2020-06-08 - 5 citationsPlasma taurine levels are not affected by vigabatrin in pediatric patients.Emily M. Spelbrink, Tarub S. Mabud, Richard J. Reimer, Brenda E. Porter
Epilepsia. 2016-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
